Annual Congress Copenhagen 2005

Saturday, 17.09.2005
Sunday, 18.09.2005
Monday, 17.09.2005
Tuesday, 20.09.2005
Wednesday, 21.09.2005

Citations should be made in the following way: Authors. Title. Eur Respir J 2005; 26: Suppl. 49, abstract number.

Material from 2005:

4063 Abstracts
739 Slide presentations
213 Webcasts
93 Handouts

Material from 2005: Show

Treatment of pulmonary arterial hypertension

Oral Presentation
Chairs: O. Sitbon (Clamart, France), J. Pepke-Zaba (Cambridge, United Kingdom)

Download all media

Deleterious effects of ß-blockers on exercise capacity and hemodynamics in portopulmonary hypertension S. Provencher, P. Hervé, V. Ioos, X. Jais, D. Lebrec, M. Humbert, G. Simonneau, O. Sitbon (Clamart, Clichy, France)
Bosentan improves exercise tolerance and Tei index in patients with pulmonary hypertension and prostanoid therapy H. J. Seyfarth, S. Hammerschmidt, H. Pankau, J. Schauer, J. Winkler, H. Wirtz (Leipzig, Germany)
Hemodynamic effects of sildenafil in pulmonary arterial hypertension (PAH) patients A. Peacock, G. Burgess, T. Parpia, R. Barst (Glasgow, Sandwich, United Kingdom; New York, United States Of America)
Sildenafil effects on 1-year survival of patients with idiopathic pulmonary arterial hypertension (IPAH) P. Corris, G. Burgess, T. Parpia, R. Barst (Newcastle upon Tyne, Sandwich, United Kingdom; New York, United States Of America)
Effects of sildenafil on 6-minute walk distance (6MWD) and WHO functional class (FC) in pulmonary arterial hypertension (PAH) patients after 1 year of treatment O. Sitbon, G. Burgess, T. Parpia, H. Ghofrani (Clamart, France; Sandwich, United Kingdom; Giessen, Germany)
Sitaxsentan treatment for patients with pulmonary arterial hypertension (PAH) failing bosentan due to lack of efficacy R. L. Benza, R. Barst (Birmingham, New York, United States Of America)
STRIDE-2 trial: a placebo-controlled study for sitaxsentan in PAH N. Galie, D. Langleben, R. Barst (Bologna, Italy; Montreal, Canada; New York, United States Of America)
Haemodynamics during vasodilator test comparing urapidil and nicardipine to NO in pulmonary arterial hypertension B. Gressens, D. Castanares, J. Jamart, P. Bulpa, E. Installé, P. Evrard (Yvoir, Belgium)